Journal article
New-onset diabetes after kidney transplantation - Changes and challenges
CJ Yates, S Fourlanos, J Hjelmesæth, PG Colman, SJ Cohney
American Journal of Transplantation | Published : 2012
Abstract
Despite substantial improvement in short-term results after kidney transplantation, increases in long-term graft survival have been modest. A significant impediment has been the morbidity and mortality attributable to cardiovascular disease (CVD). New-onset diabetes after transplantation (NODAT) is an independent predictor of cardiovascular events. This review examines recent literature surrounding diagnosis, outcomes and management of NODAT. Amongst otherwise heterogeneous studies, a common finding is the relative insensitivity of fasting blood glucose (FBG) as a screening test. Incorporating self-testing of afternoon capillary BG and glycohemoglobin (HbA 1c) detects many cases that would o..
View full abstractGrants
Funding Acknowledgements
C Yates, J Hjelmesaeth and S Fourlanos have no conflicts of interest to disclose as described by the American Journal of Transplantation. P Colman is on an advisory committee for Novartis. S Cohney has received unrestricted educational grants from Roche, Janssen Csillag and AMGEN, travel support from ROCHE and Janssen Cilag and is on an advisory committee for Novartis and Pfizer.